Arteether is a high-purity, semi-synthetic antimalarial Active Pharmaceutical Ingredient (API) derived from artemisinin. Supplied with an FDA-approved license from Maharashtra, this bulk API meets the rigorous standards of major international pharmacopeias, including IP, BP, EP, and USP. It is specifically engineered for its potent activity against Plasmodium falciparum malaria, including strains resistant to chloroquine. Available in ready stock, it provides pharmaceutical manufacturers with a reliable, compliant, and immediately accessible raw material essential for producing effective antimalarial medications, ensuring supply chain continuity for critical drug production.
This API is indispensable for the pharmaceutical industry, particularly for companies specializing in antimalarial drugs. Manufacturers of injectable formulations use it for severe malaria treatments, while producers of oral solid dosages incorporate it into tablets and combination therapies. It is a vital compone...
Arteether is a high-purity, semi-synthetic antimalarial Active Pharmaceutical Ingredient (API) derived from artemisinin. Supplied with an FDA-approved license from Maharashtra, this bulk API meets the rigorous standards of major international pharmacopeias, including IP, BP, EP, and USP. It is specifically engineered for its potent activity against Plasmodium falciparum malaria, including strains resistant to chloroquine. Available in ready stock, it provides pharmaceutical manufacturers with a reliable, compliant, and immediately accessible raw material essential for producing effective antimalarial medications, ensuring supply chain continuity for critical drug production.
This API is indispensable for the pharmaceutical industry, particularly for companies specializing in antimalarial drugs. Manufacturers of injectable formulations use it for severe malaria treatments, while producers of oral solid dosages incorporate it into tablets and combination therapies. It is a vital component for generic drug manufacturers, suppliers to government tenders, and organizations involved in global health initiatives aimed at malaria control and elimination in endemic regions, ensuring therapies remain effective against evolving resistant parasites.
Choosing this Arteether API delivers significant business value through assured reliability and regulatory simplicity. The ready stock availability minimizes production delays and inventory risks. The possession of an FDA-approved Maharashtra license streamlines the compliance process for both domestic and international buyers, facilitating smoother market entry. Consistent high purity and adherence to multiple pharmacopeial standards reduce manufacturing variability, leading to predictable yields, fewer quality rejections, and enhanced trust in the final drug product's safety and efficacy.
Key Features:
- Manufactured under an FDA-approved license from Maharashtra, ensuring regulatory compliance.
- Available in multiple pharmacopeia grades: IP, BP, EP, and USP specifications.
- Ready stock is maintained for immediate dispatch and supply chain reliability.
- High-purity API specifically effective against chloroquine-resistant malaria strains.
- Suitable for formulating both injectable and oral dosage forms.
Benefits:
- Enables uninterrupted manufacturing with readily available, in-stock API supply.
- Simplifies regulatory approval for drug manufacturers with pre-verified compliance.
- Offers formulation flexibility for injectable, tablet, and combination therapies.
- Provides consistent quality and purity, leading to reliable production outcomes.
- Supports global market access by meeting diverse international quality standards.